Skip to main content
. 2020 May 19;12(5):1283. doi: 10.3390/cancers12051283

Figure 5.

Figure 5

Effects of FASN inhibitors and EGFR TKIs on apoptosis determined by PARP cleavage. Sensitive (PC9) and Gefitinib Resistant (GR) models (PC9-GR1, PC9-GR3, and PC9-GR4) were treated for 72 h with a concentration equivalent to IC50 of each drug. Untreated cells were used as an internal control (Ctrl) and GAPDH as a loading control. Results shown are representative from at least three independent experiments.